no statement of use filed
on 05 Dec 2022
Last Applicant/ Owned by
CH-4002
Basel
CH
4002
Serial Number
88501012 filed on 04th Jul 2019
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Providing temporary use of a non-downloadable web application for processing patient information related to ophthalmology Providing medical information in the field of ophthalmic diseases and disorders; medical services, namely, assisting in the observation, monitoring, adherence and compliance of patients to medical treatments Organizing and conducting support groups in the field of ophthalmoloRead More
Organizing and conducting support groups in the field of ophthalmology; Social networking services in the field of ophthalmological diseases and disorders and the monitoring and management of said diseases and disorders provided via a website
Providing medical information in the field of ophthalmic diseases and disorders; medical services, namely, assisting in the observation, monitoring, adherence and compliance of patients to medical treatments
Providing temporary use of a non-downloadable web application for processing patient information related to ophthalmology
Educational and training services, namely, conducting classes, seminars and workshops in the field of ophthalmic diseases and disorders; providing online non-downloadable publications in the nature of articles, books and journals in the field of ophthalmic diseases and disorders and the monitoring and management of said diseases and disorders
Business administration of patient reimbursement programs; business administration of medication reimbursement programs and services; business administration of pharmacy reimbursement programs and services; doctor's appointment reminder services pertaining to patient visits to doctors, medical centers and specialists, namely, ophthalmologists
Downloadable software in the nature of a mobile application for providing information relating to the treatment of ophthalmic diseases and disorders
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma
No 88501012
No Service Mark
No
No
No
No
No
No
No
No
No
26.05.21 -
Triangles that are completely or partially shaded
26.13.13 -
Two quadrilaterals
26.13.16 -
Quadrilaterals touching or intersecting
26.13.21 -
Quadrilaterals that are completely or partially shaded
The mark consists of of two partially overlapping quadrilaterals.
| Status Date | Action Taken |
|---|---|
| 05th Dec 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| 05th Dec 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 03rd May 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 02th May 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 02th May 2022 | SOU EXTENSION 5 GRANTED |
| 25th Apr 2022 | SOU TEAS EXTENSION RECEIVED |
| 25th Apr 2022 | SOU EXTENSION 5 FILED |
| 26th Oct 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 23rd Oct 2021 | SOU TEAS EXTENSION RECEIVED |
| 23rd Oct 2021 | SOU EXTENSION 4 FILED |
